1 Hagnestam C et al. (2007): Yield losses associated with clinical mastitis occurring in different weeks of lactation. J. Dairy Sci. 90, 2260-2270.
2 Heikkilä A-M et al. (2012): Costs of clinical mastitis with special reference to premature culling. J. Dairy Sci. 95, 139-150.
3 Pol M and Ruegg PL (2007): Treatment practices and quantification of antimicrobial drug usage in conventional and organic dairy farms in
Wisconsin J. Dairy Sci. 90, 249-61.
4 Crispie F et al. (2004): Dry cow therapy with a non-antibiotic intramammary teat seal – a review. Ir. Vet. J. 57, 412-418.
5 Dingwell RT et al. (2004): Association of cow and quarter-level factors at drying-off with new intramammary infections during the dry period. Prev. Vet. Med. 63, 75-89.
6 Williamson JH et al. (1995): The prophylactic effect of a dry-cow antibiotic against Streptococcus uberis. N. Z. Vet. J. 43, 228-234.
7 Bradley A et al. (2015): An investigation of the dynamics of intramammary infections acquired during the dry period on European dairy farms. J. Dairy Sci. 98, 6029-6047.
8 Rabiee AR and Lean IJ (2013): The effect of internal teat sealant products (Teatseal and Orbeseal) on intramammary infection, clinical mastitis, and somatic cell counts in lactating dairy cows: A meta-analysis. J. Dairy Sci. 96, 6915-6931.
9 Bradley A et al. (2018): Consensus Statement Dry Cow Therapy. Proceedings 57. NMC Annual Meeting
10 Bradley A et al. (2018): Pan-Europeanagreement on dry cow therapy. Vet Rec. 182 182(22):637.